Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thierry Poynard

Showing results (151-160 of 272) with videos related to

Pageof 28
Sort By:
Hepatology (Baltimore, Md.)|May 25, 2002
Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosisVlad Ratziu, Luminita Bonyhay, Vincent Di Martino, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 21, 2012
Liver biopsy analysis has a low level of performance for diagnosis of intermediate stages of fibrosisThierry Poynard, Gilles Lenaour, Jean Christophe Vaillant, et al.
Gastroenterologie Clinique Et Biologique|July 10, 2004
Prevalence of irritable bowel syndrome (IBS) and variability of diagnostic criteriaGilles Bommelaer, Thierry Poynard, Claude Le Pen, et al.
Gastroenterologie Clinique Et Biologique|March 28, 2006
Impact of irritable bowel syndrome (IBS) on health-related quality of life (HRQOL)Michel Amouretti, Claude Le Pen, Anne-Françoise Gaudin, et al.
Cancer|April 17, 2008
Gemcitabine plus oxaliplatin (GEMOX) combined with cetuximab in patients with progressive advanced stage hepatocellular carcinoma: results of a multicenter phase 2 studyAmani Asnacios, Laetitia Fartoux, Olivier Romano, et al.
Comparative Hepatology|June 25, 2004
Intra-individual fasting versus postprandial variation of biochemical markers of liver fibrosis (FibroTest) and activity (ActiTest)Mona Munteanu, Djamila Messous, Dominique Thabut, et al.
Hepatology (Baltimore, Md.)|December 17, 2008
Liver damage underlying unexplained transaminase elevation in human immunodeficiency virus-1 mono-infected patients on antiretroviral therapyPatrick Ingiliz, Marc-Antoine Valantin, Claudine Duvivier, et al.
European Journal of Gastroenterology & Hepatology|February 7, 2018
Diagnostic performance of a new noninvasive test for nonalcoholic steatohepatitis using a simplified histological referenceThierry Poynard, Mona Munteanu, Frederic Charlotte, et al.
Clinical Chemistry|June 12, 2004
Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis CThierry Poynard, Mona Munteanu, Françoise Imbert-Bismut, et al.
Clinical Chemistry and Laboratory Medicine|April 15, 2004
Intra-laboratory analytical variability of biochemical markers of fibrosis (Fibrotest) and activity (Actitest) and reference ranges in healthy blood donorsFrançoise Imbert-Bismut, Djamila Messous, Vincent Thibault, et al.
Pageof 28

Showing results (151-160 of 272) with videos related to

Sort By:
Pageof 28
Hepatology (Baltimore, Md.)|May 25, 2002
Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosisVlad Ratziu, Luminita Bonyhay, Vincent Di Martino, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 21, 2012
Liver biopsy analysis has a low level of performance for diagnosis of intermediate stages of fibrosisThierry Poynard, Gilles Lenaour, Jean Christophe Vaillant, et al.
Gastroenterologie Clinique Et Biologique|July 10, 2004
Prevalence of irritable bowel syndrome (IBS) and variability of diagnostic criteriaGilles Bommelaer, Thierry Poynard, Claude Le Pen, et al.
Gastroenterologie Clinique Et Biologique|March 28, 2006
Impact of irritable bowel syndrome (IBS) on health-related quality of life (HRQOL)Michel Amouretti, Claude Le Pen, Anne-Françoise Gaudin, et al.
Cancer|April 17, 2008
Gemcitabine plus oxaliplatin (GEMOX) combined with cetuximab in patients with progressive advanced stage hepatocellular carcinoma: results of a multicenter phase 2 studyAmani Asnacios, Laetitia Fartoux, Olivier Romano, et al.
Comparative Hepatology|June 25, 2004
Intra-individual fasting versus postprandial variation of biochemical markers of liver fibrosis (FibroTest) and activity (ActiTest)Mona Munteanu, Djamila Messous, Dominique Thabut, et al.
Hepatology (Baltimore, Md.)|December 17, 2008
Liver damage underlying unexplained transaminase elevation in human immunodeficiency virus-1 mono-infected patients on antiretroviral therapyPatrick Ingiliz, Marc-Antoine Valantin, Claudine Duvivier, et al.
European Journal of Gastroenterology & Hepatology|February 7, 2018
Diagnostic performance of a new noninvasive test for nonalcoholic steatohepatitis using a simplified histological referenceThierry Poynard, Mona Munteanu, Frederic Charlotte, et al.
Clinical Chemistry|June 12, 2004
Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis CThierry Poynard, Mona Munteanu, Françoise Imbert-Bismut, et al.
Clinical Chemistry and Laboratory Medicine|April 15, 2004
Intra-laboratory analytical variability of biochemical markers of fibrosis (Fibrotest) and activity (Actitest) and reference ranges in healthy blood donorsFrançoise Imbert-Bismut, Djamila Messous, Vincent Thibault, et al.
Pageof 28